AtriCure, Inc. develops and provides medical devices for the treatment of atrial fibrillation and heart rhythm disorders, self-described as utilizing innovative technologies for effective ablation and related procedures.

AtriCure, Inc.

Medical Equipment Manufacturing

AtriCure Europe

AtriCure, Inc. | 37,571 followers on LinkedIn. We are passionately focused on healing the lives of those affected by Afib and pain after surgery. | AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. 

Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications.

Regional Sales Manager at AtriCure, Inc.

Brendan Huck

Manager, Physician Programs at AtriCure

Mary Dyan, MBA, PMP

Britta Gross

Valerie Storch-Willhaus

Do you have a passion for the healthcare industry and want to make an impact in the pain management market? The Senior Product Marketing Manager will develop marketing strategies, lead product launches, and contribute to the growth of our pain management franchise. Apply now at: https://okt.to/FOuJCx

Shared at #AHA24 , the DEEP Trial results demonstrate improved quality of life in patients with persistent and long-standing persistent Afib who underwent hybrid ablation and left atrial appendage exclusion with an AtriClip® device. To see more of the data, visit: https://okt.to/i1WewV American Heart Association #Afib #LAAE

The 19th edition of #NavigatingtheMaze at Hospital Clínic de Barcelona is in full swing! With over 300 cardiologists, EPs and cardiothoracic surgeons joining both in-person and online, we're exploring groundbreaking advancements in Afib treatment. Join the conversation online at: Navigatingthemaze.eu and stay up-to-date with the latest agenda by following AtriCure Europe . #CardiacSurgery #HybridAFTherapy #Epeeps

Doctors Chad Brodt, Anson Lee and Thomas Beaver discuss treatment options for symptomatic IST and a new hybrid ablation approach being evaluated in the HEAL-IST IDE Clinical Trial. Watch now: https://okt.to/2xgNS6 #ClinicalTrial #IST #Innapropriatesinustachycardia

“Our strengths can sometimes be the other’s weaknesses and vice versa.” - Dr. Chad Brodt, Cardiac EP. Hybrid AF™ Therapy brings two unique skillsets together for a team approach to long-standing persistent (LSPAF) treatment. Both trial and real-world data has demonstrated better outcomes compared to an endocardial ablation alone. See the data now at: https://okt.to/vH21r0 hashtag #HybridAFTherapy hashtag #CardiacSurgery

More coverage, fewer cycles. With a larger ball tip, cryoSPHERE® MAX provides better tissue coverage. Efficiency without compromising precision. Learn more about the innovative cryoSPHERE MAX: okt.to/pSYrQ4 #cryoNB #PainManagement

Meet the latest innovation in the AtriClip® portfolio: the AtriClip® FLEX-Mini™ Device. This new addition enhances our range of surgical LAAM devices, offering another option to exclude the LAA. Discover more about the AtriClip FLEX-Mini here: https://okt.to/3GHlW2 #AtriClip #CardiacSurgery

Meet Dorsey, a passionate music store owner who knows the importance of a steady beat. Faced with aortic valve disease, coronary disease, and Afib, his doctor, Dr. Robert Saeid Farivar , recommended addressing all three at once. After surgery, including LAA exclusion, Dorsey’s heart is back in rhythm —allowing him to get back to what he loves most. Watch his story and learn more about the importance of putting patients back in normal sinus rhythm at: actagainstafib.com #Afib #CardiacSurgery

The Isolator® Synergy ™ EnCompass® Clamp features a parallel closure mechanism that delivers consistent tissue pressure across its unique jaw shape. Combined with the trusted Synergy algorithm, EnCompass creates custom-made, column-shaped lesion specific to a tissue’s length, width and composition. Discover more: https://okt.to/7yeT4D #Cardiac #CardiacSurgery

Meet Sarah Rossman, a proud veteran and valued member of our team, as she shares her powerful story of service. We’re grateful for the brave men and women who have served our country. Your sacrifice, courage, and commitment continue to inspire us all. Happy Veteran’s Day! #VeteransDay #VeteransDay2024

3D Heart Education

Domain Not Resolving

DNSSEC

LetsEncrypt

Mobile Non Scaleable Content

nginx

Organization Schema

Google

Google Cloud

CDN JS

BootstrapCDN

Former Public Company Medtech CFO, Open for Board Opportunities

Andy Wade

Chief Financial Officer

Angie Wirick

Chief Operating Officer

Doug Seith

Owner

Jarren Dozier

Senior Associate General Counsel

Jennifer Cloyd-Caldwell

Cardiac Ablation Specialist

Josh Sunwall

Owner and Virtual Expert

Kara Tulanko

Senior Vice President, General Counsel, and Chief Legal & Compliance Officer

Karl Dahlquist

Latoya M.

Owner/Creator of Fine Jewelry

Linda Ray

Karen Prange

Robert White

Alan Kaganov

Mark Collar

B. Kristine Johnson

Thomas Hancock

Kevin Makati

Professional Educator

Tamer Ibrahim

Vice President, Research & Technology

Lee Wrubel

Associate

Michael H. Carrel

President and CEO

Mike Hooven

Founder &Director

Deborah Yount

Chief Human Resources Officer

M. Andrew Wade

VP & CFO

United States Companies that Exited (Top 10K)

Health Care Companies With More Than $1M in Revenue (Top 10K)

Medical Device Public Companies With More Than $10M in Revenue

Biotechnology Companies With More Than $1M in Revenue (Top 10K)

Headquartered near Cincinnati, Ohio, AtriCure has assembled experts in the medical device industry to form a highly effective team dedicated to serving patients, medical professionals, and investors.

Post-IPO Equity - AtriCure

Venture Round - AtriCure

U.S. Venture Partners

West Chester

Ohio

United States

North America

AtriCure

AtriCure Launches cryoSPHERE MAX Cryoablation Probe

AtriCure Marks First AtriClip FLEX-Mini Treatment

AtriCure receives expanded CE-Mark indication for AtriClip

AtriCure poised to grow Warren County workforce by 400 jobs

Piper Sandler cuts AtriCure stock price target, maintains Overweight

AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates

BTIG highlights AtriCure profitability and product launches for stock potential

AtriCure Non-GAAP EPS of -$0.17 in-line, revenue of $116.3M beats by $0.12M

AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China

A system designed for the surgical treatment of persistent and long-standing persistent atrial fibrillation.

A device used for left atrial appendage exclusion, aiming to reduce stroke risk in patients.

Utilizes cryoablation technology for the treatment of atrial fibrillation during cardiac surgery.

Approved for treating long-standing persistent atrial fibrillation, combining epicardial and endocardial RF ablation.

A probe cleared for temporary ablation of peripheral nerves to block pain in cardiac and thoracic procedures.

An advanced version of the AtriClip device designed for more efficient left atrial appendage exclusion.

The Netherlands

Europe

Malaysia

Asia

Georgia

United Kingdom

HTML5

Google Analytics

jQuery

Cloudflare CDN

Adobe Fonts

Microsoft Outlook

Facebook Comments

Bootstrap

Vimeo

Office 365

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

news impact assignment basic	general
public peers	general	Nov 18, 2024 3:10 PM	a644603c
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 3:10 PM	c6a7bb35
crunchbase trigger	general	Nov 18, 2024 3:10 PM	09a6cde5
crunchbase profile	general	Nov 19, 2024 6:16 AM	c1e919e4
li profile	general	Nov 18, 2024 3:10 PM	91e4dae6
translate crunchbase fundingrounds	general	Nov 19, 2024 6:44 AM	02e25b50
peers	general	Nov 18, 2024 3:10 PM	cb915187
news basic	general	Nov 18, 2024 3:10 PM	36a42f89
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:ATRICURE

AtriCure, Inc.

Last Close

35.68

22/11 21:00

Market Cap

1.07B

Beta: -

Volume Today

439.67K

Avg: -